Versant Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-57
Closed -$10K 1680
2020
Q1
$10K Buy
57
+8
+16% +$1.51K 0.01% 571
2019
Q4
$9K Buy
49
+30
+158% +$5.41K ﹤0.01% 758
2019
Q3
$3K Hold
19
﹤0.01% 1129
2019
Q2
$3K Sell
19
-40
-68% -$5.54K ﹤0.01% 1147
2019
Q1
$8K Sell
59
-48
-45% -$6.96K ﹤0.01% 997
2018
Q4
$14K Hold
107
0.01% 706
2018
Q3
$20K Hold
107
0.01% 654
2018
Q2
$17K Buy
107
+2
+2% +$321 0.01% 703
2018
Q1
$17K Sell
105
-74
-41% -$12.4K 0.01% 706
2017
Q4
$29K Sell
179
-3
-2% -$538 0.01% 490
2017
Q3
$37K Sell
182
-15
-8% -$3.49K 0.02% 358
2017
Q2
$47K Buy
197
+18
+10% +$4.23K 0.03% 270
2017
Q1
$42K Sell
179
-1
-0.6% -$233 0.02% 319
2016
Q4
$37K Sell
180
-37
-17% -$7.67K 0.02% 377
2016
Q3
$49K Sell
217
-5
-2% -$1.22K 0.03% 265
2016
Q2
$51K Sell
222
-2
-0.9% -$461 0.03% 231
2016
Q1
$60K Sell
224
-30
-12% -$8.59K 0.04% 196
2015
Q4
$79K Buy
+254
New +$75.6K 0.05% 153

Other funds holding AGN

Versant Capital Management's AGN Position: Q2 2020 in Review

Versant Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 57 shares — an estimated $10K sold.

Versant Capital Management first reported a position in AGN in Q4 2015 and held it in 18 quarters. The position peaked at $79K in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Versant Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Versant Capital Management sold 57 Allergan plc shares in Q2 2020, an estimated $10K.
  • Versant Capital Management first reported a position in Allergan plc in Q4 2015 and held it in 18 quarters.
  • Versant Capital Management's Allergan plc position peaked at $79K in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Versant Capital Management's 13F filing for Q2 2020, filed 16 Jul 2020.